ロード中...
Pembrolizumab in cervical cancer: latest evidence and clinical usefulness
Cervical cancer is the fourth most common cause of cancer-related deaths in women worldwide. With the development of detection of precancerous lesions and preventive human papillomavirus (HPV) vaccination program, a survival improvement has been observed in these patients in developed countries, alt...
保存先:
| 出版年: | Ther Adv Med Oncol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5455883/ https://ncbi.nlm.nih.gov/pubmed/28607581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834017708742 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|